November 20, 2020
Open to all ISPOR Members and Non-members
- Deborah Marshall, PhD
- Eric Low, MSc
- Andriy Danyliv, PhD
- John Bridges, PhD
November 20, 2020
10:00AM EST | 3:00PM GMT | 4:00PM CET
There is currently a major gap in guidance and patient preference literature on how decision makers can use patient preferences and how researchers can conduct fit-for-purpose studies that are more relevant to decision makers. The current regulatory and assessor landscape will be discussed including the European Union’s Innovative Medicines Initiative (IMI) and the Medical Device Innovation Consortium (MDIC). The task force is presenting their work to date with the request for feedback.
- In which decision contexts are patient preferences relevant?;
- How can preference studies be most relevant to decision makers?; and
- Which questions should be answered by the task force’s draft framework and preliminary recommendations?
Brought to you by: ISPOR Patient Preferences Good Practices Task Force
Deborah Marshall, PhD, Professor, University of Calgary, Calgary, AB, Canada
Eric Low, MSc, Independent Healthcare Consultant, Eric Low Consulting, Haddington, England, UK
Andriy Danyliv, PhD, Head HEOR Innovation, Novartis, Basel, Switzerland
John Bridges, PhD, Professor, Departments of Biomedical Informatics and Surgery, Ohio State University, Columbus, OH, USA
Please note: On the day of the scheduled webinar, the first 1000 registered participants will be accepted into the webinar. For those who are unable to attend, or would like to review the webinar at a later date, the full-length webinar recording will be made available at the ISPOR Educational Webinar Series webpage approximately 2 weeks after the scheduled Webinar.
Reservations are on a first-come, first-served basis.